Liver ultrasound study for fatty liver disease
Part of Digestive system clinical trials.
This study uses ultrasound to look at the liver and help classify a type of fatty liver disease called MASLD. It may help doctors better understand and diagnose this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 19 and 75 years old
- Either be a healthy volunteer with no known liver disease, or have chronic liver disease
- Be able to speak and read English
- Be able to have an MRI scan (no metal implants, pacemakers, or other MRI safety issues)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares ultrasound (DeepUSFF) and MRI (MRI-PDFF) for measuring liver fat in people with MASLD (a type of fatty liver disease not caused by alcohol). It aims to see if ultrasound can be used as a cheaper, more accessible alternative to MRI.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
This study is looking at whether people with a common fatty liver condition (MASLD) have abnormal heart rhythms. If you have MASLD and are 18 or older, you may join to help doctors see if your liver affects your heart's electrical activity.
This study compares two ultrasound measurement techniques to see which one better detects and measures fat in the liver. If you have signs of a fatty liver or are being evaluated as a potential organ donor, you may qualify.
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
This trial compares a new ultrasound technique to a standard MRI scan for measuring liver fat. It may help improve how we diagnose and monitor fatty liver disease.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.